Hunan Yiweidi Medical Equipment Co., Ltd. announced that it expects to receive CNY 50 million in funding from APT Medical Inc., Shanghai Huishen Venture Capital Center (Limited Partnership), Shanghai Huizhen Venture Capital Center (Limited Partnership)
Hunan Yiweidi Medical Equipment Co., Ltd. announced that it will receive CNY 50,000,000 in an equity round of funding on July 7, 2025. The transaction will included participation from returning investor, APT Medical Inc. which will invest CNY 36,303,270 for 53.3859% stake, new investors, Shanghai Huishen Venture Capital Center (Limited Partnership) which will invest CNY 6,848,365 for 6.3324% stake, and Shanghai Huizhen Venture Capital Center (Limited Partnership), which will invest CNY 6,848,365 for 6.3324% stake in the company. The transaction has been approved by its 2nd special meeting of independent directors for 2025 and the 23rd meeting of the 2nd board of directors of the company.
APT Medical Inc is a China-based company mainly engaged in the research and development, manufacture and sales of electrophysiological and vascular interventional medical devices. The Company's electrophysiological products include electrophysiological electrode catheters, controllable radiofrequency ablation electrode catheters and multichannel electrophysiological systems. Its coronary artery access products mainly include guide wires, micro catheters, balloons, contrast guide wires and catheters. The Company's peripheral vascular intervention products are mainly applied in peripheral vascular diseases. The Company is also engaged in related original equipment manufacturer (OEM) business. The Company distributes its products within domestic market and to overseas markets.
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Hunan Yiweidi Medical Equipment Co., Ltd. announced that it expects to receive CNY 50 million in funding from APT Medical Inc., Shanghai Huishen Venture Capital Center (Limited Partnership), Shanghai Huizhen Venture Capital Center (Limited Partnership)
